FDA-Drug2026-02-04Class IIMISBRANDING
Greenstone methylprednisolone tablets recalled for incorrect blister foil orientation causing dosing confusion
LABEL MIX UPNationwide distribution
Stop using Greenstone methylprednisolone Dosepak
Greenstone LLC is recalling methylprednisolone 4 mg Dosepak tablets (Lot #LG7675, expiring November 2026) because the blister foil is oriented incorrectly. This misalignment can make the dosing directions on the foil confusing or unclear, which could lead to taking the wrong dose.
- Check your methylprednisolone Dosepak for Lot #LG7675 with November 2026 expiration.
- Contact your pharmacy or doctor for a replacement or instructions on returning the recalled medication.
- Do not use this medication if you have this lot number.
Hazard
Labeling: Not Elsewhere Classified. Incorrect orientation of the blister foil applied to the blister cavities, which results in incorrect dosing information when following the directions on the foil.
Sold states
Nationwide within the United States
Affected count
3456 cartons
Manufactured in
100 Route 206 North, N/A, Peapack, NJ, United States
Products
methylprednisolone tablets, USP Dosepak, 4 mg, 1 Blister Card per Carton containing 21 Tablets, Rx only, Distributed by: Greenstone LLC, Peapack, NJ 07977. NDC 59762-4440-2
Official notice
https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0299-2026Don't want to check this manually?
We email you a Sunday digest of new federal recalls relevant to parents — free, no credit card. Or upgrade to as-it-happens alerts for the brands you actually own.
Get the Sunday Brief